Patents by Inventor Phil Reaston

Phil Reaston has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240115855
    Abstract: A system for management of musculoskeletal disorders (SMMD) that is designed to integrate physiological monitoring and functional assessment, i.e., muscles, nerves, brain waves, cardiac, blood flow, heat rate, range of motion, global positioning, temperature and functional abilities into a single integrated test unit. The SMMD is operated by proprietary software which utilizes wireless sensor(s) that are interchangeable, rechargeable and that can process data without the need to be connected by a cable to a computer and/or wireless device such as a smartphone. The SMMD is also capable of offering preventative assessment as well as site-specific treatment. The SMMD comprises: at least one wireless sensor, at least one prevention and evaluation device, a wireless processing circuit, a receiving and transmitting interface, and a data receiving unit produces and output that indicates a subject's test results.
    Type: Application
    Filed: October 6, 2022
    Publication date: April 11, 2024
    Inventors: Mary Reaston, Phil Reaston
  • Publication number: 20160147957
    Abstract: A system and method for a healthcare provider that facilitates the creation of baseline test data and post-loss test data to determine if an individual has experienced a legitimate work-related injury. Additionally, the HP (10) employs or retains the services of healthcare professionals (18) who provide general injury assessment. The HP (10) provides a medical diagnostic unit, which is known as an EFA, that utilizes electromyography (EMG), range-of-motion (ROM) and functional capacity assessment (FCA). The EFA receives data that pertains to an individual via a real-time communication protocol (28), or the individual's data is collected and stored on an electronic storage device (30).
    Type: Application
    Filed: November 24, 2014
    Publication date: May 26, 2016
    Inventors: Maryrose Reaston, Phil Reaston
  • Publication number: 20160100775
    Abstract: An integrated movement assessment system (IMAS) that monitors a subject's movement by utilizing electromyography (EMG), range-of-motion (ROM) and functional capacity assessment (FCA). The EMG, ROM and FCA is used in combination with proprietary software that acquires data from wireless sensors which are attached to the subject and are capable of transmitting data wirelessly. In addition to assessment, the IMA can perform baseline and post-loss comparisons that are specific to a subject's occupation. When necessary or desired, the IMAS can also provide site-specific therapy.
    Type: Application
    Filed: October 12, 2014
    Publication date: April 14, 2016
    Inventors: Mary Reaston, Phil Reaston
  • Publication number: 20150223278
    Abstract: A system and method for establishing a wireless connection that functions in combination with a first wireless-enabled device and at least one second wireless-enabled device. The devices can include a desktop computer, a laptop computer, a tablet computer, a smartphone, a cell phone, a printer or a camera The system and method functions with a conventional wireless communication protocol such as BLUETOOTH®, ZipBee or WiFi. A proprietary software program facilitates the first device identifying and establishing a wireless connection with the at least one second device, without the use of conventional pairing functionality.
    Type: Application
    Filed: February 3, 2014
    Publication date: August 6, 2015
    Inventors: Mary Reaston, Phil Reaston
  • Publication number: 20150126893
    Abstract: A method for determining if surgically-implanted cervical, thoracic or lumbar hardware should be removed from an individual. The method utilizes diagnostic data acquired from a test protocol performed by an electrodiagnostics functional assessment (EFA) device. The diagnostic data is selected from the group consisting of electromyography (EMG), range-of-motion (ROM), functional capacity assessment (ECA), muscle data, myofascial data, structural data, nerve data or ischemic data.
    Type: Application
    Filed: November 1, 2013
    Publication date: May 7, 2015
    Inventors: Maryrose Cusimano Reaston, Frank J. Tomecek, JR., Phil Reaston
  • Patent number: 8568312
    Abstract: An Electro Diagnostic Functional Assessment Unit (EFA-3) that is designed to wirelessly monitor muscle group activity and to provide treatment for humans and animals. The muscle groups include the body, fascial, cervical, thoracic, upper and lower extremities, lumbosacral, bladder, cardiac, and rectal. In large animals the muscle groups include torso, legs, neck and face. The EFA-3 simultaneously correlates the muscle activity EMG with cardiac activity, nerve activity, heart rate, blood flow and brain activity with range-of-motion, grip and pinch assessment and a functional assessment in humans. The EFA-3 is operated by proprietary software (78) which provides testing protocols by utilizing a set of wireless sensor(s) (14-40) that are interchangeable and rechargeable. The treatment includes ultrasound, heat, cold, massage and electrical stimulation.
    Type: Grant
    Filed: March 12, 2010
    Date of Patent: October 29, 2013
    Inventors: MaryRose Cusimano Reaston, Phil Reaston
  • Patent number: 8535224
    Abstract: An electro diagnostic functional assessment unit (EFA-2) that diagnoses age of and treats soft tissue injuries. The EFA-2 utilizes sensor(s) including EMG, Range of Motion, FCE, pinch and grip, and allows for monitoring of muscles and muscle groups to ascertain compliance, pain and function. The EFA-2 also monitors disc pathology and determines whether a person requires surgery or conservative care and, the age of the disc. Additionally, the EFA-2 monitors EEK activity and NCV, as well as invasive EMG that monitors nerve damage. Previously, with NCV the temperature and the position of electrodes would effect readings and produce false positive or false negative readings. The EFA-2 eliminates these problems by incorporating temperature sensor(s) and electrode placement sensor(s). The EFA-2 also provides direct treatment by means of ultrasound and electrical stimulation. Thus, the EFA-2 allows diagnosis any treatment by means of a single unit.
    Type: Grant
    Filed: February 18, 2010
    Date of Patent: September 17, 2013
    Inventors: MaryRose Cusimano Reaston, Phil Reaston
  • Patent number: 8117047
    Abstract: A business model for a healthcare provider organization (10) (HPO) which comprises a preferred provider network (PPO) or other membership agreement that allows individuals or groups to join via a membership contract. The contract allows the HPO (10) to provide a technical component of a medical evaluation or service (16). Additionally, the HPO (10) employs or retains the services of healthcare professionals (18) who participate in and monitor an evaluation of a patient (20) who can be at a remote location from the healthcare professional. The HPO (10) provides a medical diagnostic unit (24), which is known as an EFA-2, that allows the healthcare professional to receive data that pertains to the patient (20) via a real-time communication protocol (28), or the patient data is collected and stored on an electronic storage device (30). The healthcare professional then analyzes the patient data and issues recommended treatment.
    Type: Grant
    Filed: April 16, 2007
    Date of Patent: February 14, 2012
    Assignee: Insight Diagnostics Inc.
    Inventors: Mary Rose Cusimano-Reaston, Phil Reaston
  • Publication number: 20110224503
    Abstract: An Electro Diagnostic Functional Assessment Unit (EFA-3) that is designed to wirelessly monitor muscle group activity and to provide treatment for humans and animals. The muscle groups include the body, fascial, cervical, thoracic, upper and lower extremities, lumbosacral, bladder, cardiac, and rectal. In large animals the muscle groups include torso, legs, neck and face. The EFA-3 simultaneously correlates the muscle activity EMG with cardiac activity, nerve activity, heart rate, blood flow and brain activity with range-of-motion, grip and pinch assessment and a functional assessment in humans. The EFA-3 is operated by proprietary software (78) which provides testing protocols by utilizing a set of wireless sensor(s) (14-40) that are interchangeable and rechargeable. The treatment includes ultrasound, heat, cold, massage and electrical stimulation.
    Type: Application
    Filed: March 12, 2010
    Publication date: September 15, 2011
    Inventors: MaryRose Cusimano Reaston, Phil Reaston
  • Publication number: 20110201904
    Abstract: An electro diagnostic functional assessment unit (EFA-2) that diagnoses age of and treats soft tissue injuries. The EFA-2 utilizes sensor(s) including EMG, Range of Motion, FCE, pinch and grip, and allows for monitoring of muscles and muscle groups to ascertain compliance, pain and function. The EFA-2 also monitors disc pathology and determines whether a person requires surgery or conservative care and, the age of the disc. Additionally, the EFA-2 monitors EEK activity and NCV, as well as invasive EMG that monitors nerve damage. Previously, with NCV the temperature and the position of electrodes would effect readings and produce false positive or false negative readings. The EFA-2 eliminates these problems by incorporating temperature sensor(s) and electrode placement sensor(s). The EFA-2 also provides direct treatment by means of ultrasound and electrical stimulation. Thus, the EFA-2 allows diagnosis any treatment by means of a single unit.
    Type: Application
    Filed: February 18, 2010
    Publication date: August 18, 2011
    Inventors: Mary Rose Cusimano Reaston, Phil Reaston